|
CADASIL
|
C14.907.253.329.249 |
|
|
Carboxyl and Carbamoyl Transferases
|
D08.811.913.555.275 |
|
|
Agrin
|
D12.776.631.050 |
|
|
Caspase 2
|
D08.811.277.656.300.200.126.550.200 |
|
|
Radon
|
D01.268.271.800 |
|
|
Oral Submucous Fibrosis
|
C07.465.654 |
|
|
Antihyperkalemic Agents
|
D065067 |
[Compounds used to lower excessive POTASSIUM levels in the body.
] |
|
Sleep Medicine Specialty
|
H02.403.429.865 |
|
|
Internal Medicine
|
H02.403.429 |
|
|
NF-E2 Transcription Factor
|
D12.776.260.235.750 |
|
|
Therapeutic Equivalency
|
G03.787.559 |
|
|
Pharmacokinetics
|
G03.787 |
|
|
Chromosomes, Human, Pair 6
|
G05.360.162.520.300.325.330 |
|
|
Separase
|
D12.776.167.552 |
|
|
Calbindin 1
|
D12.776.631.087 |
|
|
Albinism, Ocular
|
C16.320.290.040.090 |
|
|
Hernia, Abdominal
|
C23.300.707.374 |
|
|
United States Office of Economic Opportunity
|
I01.409.418.750.996 |
|
|
United States Office of National Drug Control Policy
|
I01.409.418.750.997 |
|
|
United States Office of Technology Assessment
|
I01.409.418.750.998 |
|
